Immunoassay Market 1 14

Vaccines Market Size to Worth Around USD 54,153 Mn by 2027


New York, United States: The Report on Vaccines Market by Decisive Markets Insights was released in the middle of Covid -19 after a thorough analysis of the top players and primary interviews with key industry figures. A market study from Vaccines Market examines the market size, segmentation, future trends, growth rate, drivers and challenges, as well as the sales channels and distributors. The global Vaccines market gathered revenue around USD 32,520 Million in 2020 and market is set to grow USD 54,153 Million by the end of 2027 and is estimated to expand at a modest CAGR of 8.1% during the prediction period 2021 to 2027.

Overview of Vaccines Market Study

Vaccines market study conducted by Nova One Advisor is intended at helping stakeholders get a comprehensive overview of potential challenges and undiscovered opportunities. The report offers exclusive insights to help companies and their customers to make informed decision to sustain growth through the assessment period.

Get your Customized Research Report@

Growth Factors:

The growth of this market is majorly attributed to the high prevalence of infectious diseases, increasing company initiatives to enhance vaccine R&D, growing government support for vaccine development, and the rising focus on immunization. However, the huge capital investments required for developing vaccines may restrain market growth.

Pediatric patients segment accounted for the larger share of the vaccines market, by patient type.
On the basis of patient type, the vaccines market is segmented into pediatric and adult patients. The pediatric patients segment accounted for the largest share of the global vaccines market in 2018. This can be attributed to the increasing government initiatives for immunization and the rising prevalence of diseases.

By technology, the conjugate vaccines segment accounted for the largest market share in 2020.
On the basis of technology, the vaccines market is segmented into conjugate vaccines, inactivated and subunit vaccines, live attenuated vaccines, recombinant vaccines, and toxoid vaccines. In 2018, the conjugate vaccines segment accounted for the largest share of the vaccines market. The large share of this segment can be attributed to increasing government support and rising company investments in conjugate vaccine development.

Intramuscular & subcutaneous administration segment to witness the highest growth during the forecast period
On the basis of the route of administration, the vaccines market is segmented into intramuscular and subcutaneous administration, oral administration, and other routes of administration. The intramuscular and subcutaneous administration segment accounted for the largest share of the global vaccines market in 2018 and is projected to register the highest CAGR during the forecast period. This mode of administration is associated with better immune response and a lower rate of injection site reactions.

Buy Complete Assessment of Vaccines market Now@

COVID-19 Impact on Vaccines Sales

Businesses today are operating in a dynamic environment. Earlier focus primarily concentrated on keeping pace with changing consumer preferences. COVID-19 outbreak was unprecedented and exposed vulnerabilities of various industries. Pandemic-induces obstacles also were registered in the Vaccines market.

Sales plummeted as COVID-19 gradually tightened its noose worldwide. Supply-chain disruptions caused massive losses, while demand took nose-dive as consumers remained indoors with affected countries implementing either partial or complete lockdown.

Gradual recovery however is on the cards with the roll out of vaccinations. Nonetheless, consecutive waves of the virus compelled businesses to stay prepared for the worst. As government and healthcare organizations successfully implement steps to contain the spread of COVID-19, industries have begun operations, albeit at a slow and more cautious pace.

Against this backdrop, Nova one advisor’s study predicts gradual recovery for the Vaccines market 2021 onwards. This trend will however continue through the course of the report’s assessment period

Key Players:

This report provides detailed company profiles of the key market players. This research report also highlights the competitive landscape of the Vaccines market and ranks noticeable companies as per their occurrence in diverse regions across globe and crucial developments initiated by them in the market space. This research study also tracks and evaluates competitive developments, such as collaborations, partnerships, and agreements, mergers and acquisitions; novel product introductions and developments, promotion strategies and Research and Development (R&D) activities in the marketplace. The competitive profiling of these players includes business and financial overview, gross margin, production, sales, and recent developments which can aid in assessing competition in the market.

Some of the prominent players in the Vaccines market include: 

 GlaxoSmithKline plc. (UK), Pfizer, Inc. (US), Merck & Co., Inc. (US), and Sanofi Pasteur SA (France). Other prominent players in this market include CSL Limited (Australia), Emergent BioSolutions, Inc. (US), Johnson & Johnson (US), Serum Institute of India (India), AstraZeneca (UK), Bavarian Nordic (Denmark), Mitsubishi Tanabe Pharma Corporation (Japan), and Daiichi Sankyo Company, Limited (Japan).

Unravelling the Critical Segments

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:

Market Segments

By Technology type

  • Recombinant & Conjugate Vaccines
  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Toxoid Vaccines
  • Others

By Indication

  • Pneumococcal Disease
  • Influenza
  • Human Papilloma Virus
  • Meningococcal Disease
  • Rotavirus
  • Varicella, Measles, Mumps, & Rubella
  • Diphtheria, Pertussis, & Tetanus {DPT}
  • Polio
  • Hepatitis
  • Other Indications

By End User

  • Pediatric
  • Adults
  • Travelers

North America dominates the vaccines market
North America accounted for the largest share of the vaccines market in 2020. The large share of North America in the global vaccines market is attributed to the high prevalence of infectious diseases and increasing investments by government and non-government organizations for vaccine development. The market in Asia, on the other hand, is projected to register the highest growth during the forecast period. Factors such as the increasing healthcare expenditure and increasing disposable income, government initiatives, and the presence of a large patient population are driving the growth of the vaccines market in Asia.

Why Buy this Report?

The purpose of Nova one advisor’s Vaccines market study is to provide stakeholders with a detailed picture of potential barriers and untapped opportunities. The report contains exclusive information to assist businesses in making informed decisions about how to maintain growth throughout the assessment period.

Download This Full Research Report, Click Here@

About Us

Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333



James Root

James Root have over 6+ years of experience working in business development, and customer retention. I’ve gained my experience through serving higher education, healthcare, automotive, aerospace, manufacturing, local government and hospitality businesses with technical solutions.

View all posts by James Root →

Leave a Reply

Your email address will not be published.